Acute mastoiditis in cochlear implanted children: A single-centre experience

IF 0.9 Q3 OTORHINOLARYNGOLOGY
Andrea Ciorba, Virginia Fancello, Beatrice Sacchet, Michela Borin, Nicola Malagutti, Chiara Bianchini, Francesco Stomeo, Stefano Pelucchi
{"title":"Acute mastoiditis in cochlear implanted children: A single-centre experience","authors":"Andrea Ciorba,&nbsp;Virginia Fancello,&nbsp;Beatrice Sacchet,&nbsp;Michela Borin,&nbsp;Nicola Malagutti,&nbsp;Chiara Bianchini,&nbsp;Francesco Stomeo,&nbsp;Stefano Pelucchi","doi":"10.1016/j.otorri.2023.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Acute mastoiditis<span> (AM) is the most common complication of acute otitis media<span> and primarily affects children under the age of two; current data on its prevalence in paediatric patients with cochlear implant (CI) are still scant. Proper management of AM in CI children is crucial in order to avoid the implications (financial and emotional) of an explant.</span></span></p><p>Aim of this paper is to describe the cases of AM occurred among young patients with CI in follow up at our department, also in order to evaluate its prevalence, potential predisposing factors, clinical course and therapeutic strategies.</p></div><div><h3>Patients and methods</h3><p>Retrospective study. Medical records<span> of all paediatric patients with CI, who had at least one year of follow-up, were searched aiming to identify those who developed AM, from January 1st 2002 to January 31st 2022. The following data were collected and analysed: demographic features, implant type and side, interval between CI surgery and AM, treatment, laboratory tests, clinical course, vaccination history, associated diseases.</span></p></div><div><h3>Results</h3><p>AM was developed by six (1.3%) of the 439 children with CI (541 implanted ears). In total, 9 episodes (2.05 %) were recorded, as three patients reported two consecutive infections. Average time interval between CI surgery, to the first or only AM diagnosis, was 13.8 months (range 3–30 months). Furthermore, 3/6 of patients had a history of recurrent acute otitis media; 2/6 an autism spectrum disorder<span><span>, associated to a combined immune deficiency in one case. All patients were hospitalized and promptly treated by intravenous antibiotic therapy; 4/6 also underwent a </span>mastoidectomy. CI was not explanted in any cases of this series.</span></p></div><div><h3>Conclusions</h3><p>Over a 20-year period, AM rate in CI children was 1.3%, which is consistent with the current literature rates of 1–4.7%. All cases were successfully treated, preserving the integrity of the device. In our experience, the early parenteral antibiotic therapy and, when necessary, surgical treatment were adequate to eradicate the infection.</p></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta otorrinolaringologica espanola","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0001651923000638","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Acute mastoiditis (AM) is the most common complication of acute otitis media and primarily affects children under the age of two; current data on its prevalence in paediatric patients with cochlear implant (CI) are still scant. Proper management of AM in CI children is crucial in order to avoid the implications (financial and emotional) of an explant.

Aim of this paper is to describe the cases of AM occurred among young patients with CI in follow up at our department, also in order to evaluate its prevalence, potential predisposing factors, clinical course and therapeutic strategies.

Patients and methods

Retrospective study. Medical records of all paediatric patients with CI, who had at least one year of follow-up, were searched aiming to identify those who developed AM, from January 1st 2002 to January 31st 2022. The following data were collected and analysed: demographic features, implant type and side, interval between CI surgery and AM, treatment, laboratory tests, clinical course, vaccination history, associated diseases.

Results

AM was developed by six (1.3%) of the 439 children with CI (541 implanted ears). In total, 9 episodes (2.05 %) were recorded, as three patients reported two consecutive infections. Average time interval between CI surgery, to the first or only AM diagnosis, was 13.8 months (range 3–30 months). Furthermore, 3/6 of patients had a history of recurrent acute otitis media; 2/6 an autism spectrum disorder, associated to a combined immune deficiency in one case. All patients were hospitalized and promptly treated by intravenous antibiotic therapy; 4/6 also underwent a mastoidectomy. CI was not explanted in any cases of this series.

Conclusions

Over a 20-year period, AM rate in CI children was 1.3%, which is consistent with the current literature rates of 1–4.7%. All cases were successfully treated, preserving the integrity of the device. In our experience, the early parenteral antibiotic therapy and, when necessary, surgical treatment were adequate to eradicate the infection.

人工耳蜗植入儿童的急性乳突炎:单中心经验
背景急性乳突炎(AM)是急性中耳炎最常见的并发症,主要影响两岁以下的儿童;目前有关其在植入人工耳蜗(CI)的儿童患者中发病率的数据仍然很少。本文旨在描述我科随访的年轻人工耳蜗患者中发生急性中耳炎的病例,同时评估其发病率、潜在诱发因素、临床过程和治疗策略。研究人员检索了 2002 年 1 月 1 日至 2022 年 1 月 31 日期间随访至少一年的所有儿科 CI 患者的病历,旨在找出那些出现 AM 的患者。研究收集并分析了以下数据:人口统计学特征、植入物类型和植入侧、CI手术与AM之间的间隔时间、治疗、实验室检查、临床过程、疫苗接种史、相关疾病。总共有 9 例(2.05%),其中有 3 名患者连续感染两次。从 CI 手术到首次或唯一一次急性髓系白血病确诊的平均间隔时间为 13.8 个月(3-30 个月)。此外,3/6 的患者有复发性急性中耳炎病史;2/6 的患者有自闭症谱系障碍,其中一例与合并免疫缺陷有关。所有患者均住院并接受了及时的静脉抗生素治疗;4/6 的患者还接受了乳突切除术。结论20年来,CI患儿的AM发生率为1.3%,与目前文献报道的1-4.7%一致。所有病例都得到了成功治疗,保持了装置的完整性。根据我们的经验,早期肠外抗生素治疗以及必要时的手术治疗足以根除感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
20.00%
发文量
44
审稿时长
44 days
期刊介绍: Es la revista más importante en español dedicada a la especialidad. Ofrece progresos científicos y técnicos tanto a nivel de originales como de casos clínicos. Además, es la Publicación Oficial de la Sociedad Española de Otorrinolaringología y Patología Cérvico-Facial y está presente en los más prestigiosos índices de referencia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信